European Multidisciplinary Cancer Conference 2011 (ECCO ESMO ESTRO)
Stockholm, Sweden - 23 Sep - 27 Sep 2011
We are pleased to report that The European Multidisciplinary Cancer Congress was a great success with the participation of almost 16,000 people from 116 countries!
Video highlights (exclusively by ESMO)
ESMO interviews Alberto Sobrero, MD, PhD about the results of a phase III study of aflibercept versus placebo in combination with Folfiri for the treatment of patients with previously-treated metastatic colorectal cancer (VELOUR).
More videos from EMCC 2011 on ESMO Youtube Channel:
- Interview with Fabrice André : an independent expert comment on the impact of the ph-III BOLERO-2 study and a perspective on clinical practice consequences for patients with hormone refractory advanced breast cancer
- Interview with Karim Fizazi : Radium-223 Chloride proved to be effective in the treatment of patients with symptomatic bone metastases in castration-resistant prostrate cancer
- Interview with Fortunato Ciardiello : VANTAGE 014 – urgent need to identify new drugs against advanced pleural mesothelioma to face peack of cases in 10 years
If you have any questions about webcasts, certificates of attendance or poster certificates, abstracts, press releases, etc., please contact the European Cancer Organisation (ECCO)